Select Publications
Journal articles
2013, 'Allopurinol hypersensitivity: A systematic review of all published cases, 1950-2012', Drug Safety, 36, pp. 953 - 980, http://dx.doi.org/10.1007/s40264-013-0084-0
,2013, 'Compliance with antibiotic prescribing policy: Perspectives of policymakers and prescribers', Australian Journal of Pharmacy, 94, pp. 74 - 77
,2013, 'Benzbromarone: Availability for general prescribing in New Zealand (a response to letters by Dr Lance Gravatt on benzbromarone)', New Zealand Medical Journal, 126, pp. 124 - 126
,2013, 'PACE - the first placebo controlled trial of paracetamol for acute low back pain: Statistical analysis plan', Trials, 14, http://dx.doi.org/10.1186/1745-6215-14-248
,2013, 'Understanding compliance to an antibiotic prescribing policy: Perspectives of policymakers and prescribers', Journal of Pharmacy Practice and Research, 43, pp. 32 - 36
,2013, 'Identifying effective strategies to prevent drug-drug interactions in hospital: A user-centered approach', 49th Annual Human Factors and Ergonomics Society of Australia Conference 2013, HFESA 2013
,2013, 'Off-label prescribing', Australian Prescriber, 36, pp. 182 - 183, http://dx.doi.org/10.18773/austprescr.2013.075
,2013, 'A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus', Internal Medicine Journal, 43, pp. 547 - 553, http://dx.doi.org/10.1111/imj.12100
,2013, 'Antifungal Use and Therapeutic Monitoring of Plasma Concentrations of Itraconazole in Heart and Lung Transplantation Patients.', Therapeutic Drug Monitoring, 35, pp. 133 - 136, http://dx.doi.org/10.1097/FTD.0b013e318275fe69
,2013, 'Comparing dose prediction software used to manage gentamicin dosing', Internal Medicine Journal, 43, pp. 519 - 525, http://dx.doi.org/10.1111/imj.12067
,2013, 'Formoterol, a highly selective beta 2-selective agonist, increases energy expenditure and fat utilisation in men', International journal of obesity, 37, pp. 593 - 597, http://dx.doi.org/10.1038/ijo.2012.90
,2013, 'Formulating an ethics agenda for drug development, regulation, and utilization', Therapeutic Innovation & Regulatory Science, 47, pp. 46 - 49, http://dx.doi.org/10.1177/2168479012469949
,2013, 'HLA-B*5801 should be used to screen for risk of Stevens-Johnson Syndrome (SJS) in family members of Han-Chinese patients commencing allopurinol therapy', Journal of Rheumatology, 40, pp. 96 - 97, http://dx.doi.org/10.3899/jrheum.120803
,2013, 'Multidisciplinary diabetes team care: The experiences of young adults with Type 1 diabetes', Health Expectations, http://dx.doi.org/10.1111/hex.12170
,2013, 'Non-steroidal anti-inflammatory drugs (NSAIDs)', BMJ, 346, pp. Article No. f3195, http://dx.doi.org/10.1136/bmj.f3195
,2013, 'Overcoming Entrenched Disagreements: the Case of Misoprostol for Post-Partum Haemorrhage', Developing World Bioethics, pp. n/a - n/a, http://dx.doi.org/10.1111/dewb.12040
,2013, 'Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes: Simulation of doses according to renal function', Clinical Pharmacokinetics, 52, pp. 373 - 384, http://dx.doi.org/10.1007/s40262-013-0046-9
,2013, 'PRECISE - pregabalin in addition to usual care for sciatica: study protocol for a randomised controlled trial', Trials, 14, pp. 213, http://dx.doi.org/10.1186/1745-6215-14-213
,2013, 'The management of severe hypertension in Australian general practice', BMC health services research, 13, pp. 414, http://dx.doi.org/10.1186/1472-6963-13-414
,2013, 'The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.', Inflammopharmacology, 21, pp. 201 - 232, http://dx.doi.org/10.1007/s10787-013-0172-x
,2012, 'Successful use of allopurinol in a patient on dialysis.', BMJ case reports, 2012
,2012, 'CareTrack: assessing the appropriateness of health care delivery in Australia REPLY', MEDICAL JOURNAL OF AUSTRALIA, 197, pp. 549 - 550, http://dx.doi.org/10.5694/mja12.11210
,2012, 'CareTrack Australia: assessing the appropriateness of adult healthcare: Protocol for a retrospective medical record review', BMJ Open, 2, pp. 665, http://dx.doi.org/10.1136/bmjopen-2011-000665
,2012, 'CareTrack: Assessing the appropriateness of health care delivery in Australia', Medical Journal of Australia, 197, pp. 100 - 105, http://dx.doi.org/10.5694/mja12.10510
,2012, 'Consistency or efficiency? A dilemma for designers', Journal of the American Medical Informatics Association, 19, pp. 1119 - 1120, http://dx.doi.org/10.1136/amiajnl-2012-001254
,2012, 'Drug policy at the margins: The case of growth hormone replacement for adults with severe growth hormone deficiency', Medical Journal of Australia, 197, pp. 204 - 205, http://dx.doi.org/10.5694/mja11.11572
,2012, 'Effects of two commercial electronic prescribing systems on prescribing error rates in hospital inpatients: a before and after study', PLOS Medicine, 9, pp. e1001164, http://dx.doi.org/10.1371/journal.pmed.1001164
,2012, 'Evidence and desperation in off-label prescribing: Recombinant factor VIIa', British Medical Journal: International, 344, pp. d7926, http://dx.doi.org/10.1136/bmj.d7926
,2012, 'Failure to utilize functions of an electronic prescribing system and the subsequent generation of 'technically preventable' computerized alerts', Journal of the American Medical Informatics Association, 19, pp. 1003 - 1010, http://dx.doi.org/10.1136/amiajnl-2011-000730
,2012, 'Fractional clearance of urate: Validation of measurement in spot urine samples in healthy subjects and gouty patients', Arthritis Research and Therapy, 14, pp. R189 - R197, http://dx.doi.org/10.1186/ar4020
,2012, 'Implementation of revised aminoglycoside guidelines: Australian hospitals 'left in the lurch'', Journal of Pharmacy Practice and Research, 42, pp. 178 - 179
,2012, 'Initiating allopurinol therapy: Do we need to know the patient's human leucocyte antigen status?', Internal Medicine Journal, 42, pp. 411 - 416, http://dx.doi.org/10.1111/j.1445-5994.2011.02567.x
,2012, 'Learning from Hackers: Open-Source Clinical Trials', Science Translational Medicine, 4, pp. 132cm5, http://stm.sciencemag.org/cgi/rapidpdf/4/132/132cm5?ijkey=r6Ku/MbAUiQyE&keytype=ref&siteid=scitransmed
,2012, 'Metformin therapy in patients with chronic kidney disease', Diabetes Obesity and Metabolism, 14, pp. 963 - 965, http://dx.doi.org/10.1111/j.1463-1326.2012.01617.x
,2012, 'Nation-scale adoption of new medicines by doctors: an application of the Bass diffusion model', BMC health services research, 12, pp. 248 - 248, http://dx.doi.org/10.1186/1472-6963-12-248
,2012, 'No evidence or no alternative? Taking responsibility for off-label prescribing', Internal Medicine Journal, 42, pp. 247 - 251, http://dx.doi.org/10.1111/j.1445-5994.2012.02713.x
,2012, 'Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease', British Journal of Clinical Pharmacology, 73, pp. 828 - 829, http://dx.doi.org/10.1111/j.1365-2125.2011.04147.x
,2012, 'Successful use of allopurinol in a patient on dialysis', BMJ Case Reports, 2012, pp. 1 - 3, http://dx.doi.org/10.1136/bcr.02.2012.5814
,2012, 'The pharmacokinetics of oxypurinol in people with gout', British Journal of Clinical Pharacology, 74, pp. 477 - 489, http://dx.doi.org/10.1111/j.1365-2125.2012.04207.x
,2012, 'The role and impact of research agendas on the comparative effectiveness research amongst anti-hyperlipidemics', Clinical Pharmacology and Therapeutics, 91, pp. 685 - 691, http://dx.doi.org/10.1038/clpt.2011.279
,2012, 'Time for the Pharmaceutical Benefits Advisory Committee to set its own agenda', Medical Journal of Australia, 196, pp. 374 - 375
,2012, 'Towards the delivery appropriate healthcare in Australia', Medical Journal of Australia, 197, pp. 78 - 81, http://dx.doi.org/10.5694/mja12.10799
,2012, 'Understanding doctors perceptions of their prescribing competency and the value they ascribe to an electronic prescribing system', Studies in Health Technology and Informatics,Volume 178: Health Informatics: Building a Healthcare Future Through Trusted Information, 178, pp. 1 - 6, http://dx.doi.org/10.3233/978-1-61499-078-9-1
,2012, 'Wrong questions, wrong answers? Are we getting the drugs we need?', Clinical Pharmacology and Therapeutics, 91, pp. 367 - 369, http://dx.doi.org/10.1038/clpt.2011.335
,2011, 'What's in a name? Brand name confusion and generic medicines', Medical Journal of Australia, 195, pp. 650 - 651, http://dx.doi.org/10.5694/mja10.10968
,2011, 'Rethinking the discordance between guidelines and practice in rheumatoid arthritis treatment', Medical Journal of Australia, 195, pp. 446 - 447, http://dx.doi.org/10.5694/mja11.10068
,2011, 'Thomas W. Teal In Memoriam', DRUG INFORMATION JOURNAL, 45, pp. II - II, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000292237400001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'ESTABLISHING THE USEFULNESS OF A SPOT URINE COLLECTION IN CALCULATING THE FRACTIONAL RENAL CLEARANCE OF URATE (FCU)', INTERNAL MEDICINE JOURNAL, 41, pp. 31 - 31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290489900106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'INDIVIDUALISING ALLOPURINOL THERAPY IN GOUT', INTERNAL MEDICINE JOURNAL, 41, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290489900103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'Death and morbidity from supratherapeutic dosing of colchicine', Medical Journal of Australia, 194, pp. 612 - 613, http://dx.doi.org/10.5694/j.1326-5377.2011.tb03121.x
,